Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine in African Children (PAC study)
ISRCTN11594437Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of primaquine, artemether + lumefantrine and dihydroartemisinin + piperaquine in Malaria (4 arms), sponsored by University of Oxford. Primary endpoints: Profound anaemia and Severe anaemia with clinical features of severe malaria. Started Jul 2017; status: completed.
02
Drugs
primaquineartemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN11594437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11594437.